Target intelligence / Profile preview

Other Neurotransmitters

Molecular classification
Other
01

Overview

"Other Neurotransmitters" is a broad taxonomic grouping used in pharmacology and biochemistry to classify signaling molecules that do not fall into the primary families of amino acids, biogenic amines, or neuropeptides. This catch-all category typically includes diverse chemical species such as purines (e.g., adenosine, ATP), trace amines (e.g., tyramine, phenethylamine), and gasotransmitters (e.g., nitric oxide, carbon monoxide). Because the term identifies a heterogeneous collection of chemical messengers rather than a specific protein, receptor, or enzyme, it does not function as a discrete therapeutic target for drug development. In pharmaceutical databases, this label is often utilized as a placeholder or a classification bucket for ligands whose mechanisms of action involve less common or non-classical signaling pathways. Consequently, while the individual molecules within this group may be involved in various neurological or psychiatric disorders, the category itself lacks a unified mechanism of action or safety profile, making it an imprecise designation for target-based drug discovery.

Other names
Miscellaneous neurotransmittersNon-classical neurotransmittersUnclassified neurotransmittersNon-traditional neurotransmitters
02

Mechanism of action

Not applicable as this is a categorical grouping rather than a specific molecular target.

03

Biological functions

Signal transductionNeurotransmission
04

Disease associations

Other
05

Safety considerations

Non-specificity of the term makes safety profile assessment impossible

Beyond the preview

Go deeper on Other Neurotransmitters.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Other Neurotransmitters.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call